tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market
Advertisement

Glenmark Pharmaceuticals Limited (GLENMARK) Income Statement

Compare
3 Followers

Glenmark Pharmaceuticals Limited Income Statement

Last quarter (Q1 2026), Glenmark Pharmaceuticals Limited's total revenue was ₹32.64B, an increase of 0.62% from the same quarter last year. In Q1, Glenmark Pharmaceuticals Limited's net income was ₹468.71M. See Glenmark Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 133.63B₹ 126.45B₹ 116.56B₹ 123.05B₹ 109.44B
Gross Profit
₹ 88.38B₹ 80.66B₹ 72.45B₹ 77.57B₹ 70.97B
Operating Expenses
₹ 46.55B₹ 46.72B₹ 44.33B₹ 41.96B₹ 41.29B
Depreciation and Amortization
₹ 2.61B₹ 3.84B₹ 2.91B₹ 723.93M₹ 2.29B
EBITDA
₹ 21.68B₹ 18.30B₹ 14.29B₹ 19.12B₹ 19.45B
Operating Income
₹ 41.84B₹ 33.94B₹ 28.11B₹ 35.60B₹ 29.68B
Other Income/Expenses
₹ -27.85B₹ -33.58B₹ -25.72B₹ -21.19B₹ -15.86B
Pretax Income
₹ 13.99B₹ 364.95M₹ 2.40B₹ 14.41B₹ 13.82B
Net Income
₹ 10.47B₹ -15.02B₹ 2.97B₹ 9.42B₹ 9.70B
Per Share Metrics
Basic EPS
₹ 37.11₹ -67.30₹ -6.01₹ 33.37₹ 34.38
Diluted EPS
₹ 37.11₹ -67.30₹ -6.01₹ 33.37₹ 34.38
Weighted Average Shares Outstanding
282.19M 282.17M 282.17M 282.20M 282.17M
Weighted Average Shares Outstanding (Diluted)
282.21M 282.18M 282.17M 282.17M 282.17M
Currency in INR

Glenmark Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis